Published in Am J Trop Med Hyg on July 01, 2002
Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med (2005) 3.91
In vivo assessment of drug efficacy against Plasmodium falciparum malaria: duration of follow-up. Antimicrob Agents Chemother (2004) 2.77
Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in Senegal. Malar J (2007) 2.26
Antimalarial drug discovery - approaches and progress towards new medicines. Nat Rev Microbiol (2013) 1.60
Safety and efficacy of co-trimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review. PLoS One (2013) 1.29
Safety and efficacy of methylene blue combined with artesunate or amodiaquine for uncomplicated falciparum malaria: a randomized controlled trial from Burkina Faso. PLoS One (2008) 1.22
Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Colombia. Malar J (2007) 1.19
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine. Malar J (2010) 1.19
Can changes in malaria transmission intensity explain prolonged protection and contribute to high protective efficacy of intermittent preventive treatment for malaria in infants? Malar J (2008) 1.14
Varying efficacy of intermittent preventive treatment for malaria in infants in two similar trials: public health implications. Malar J (2007) 1.09
Modelling the epidemiological impact of intermittent preventive treatment against malaria in infants. PLoS One (2008) 1.04
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance. PLoS One (2010) 1.04
In vitro amodiaquine resistance and its association with mutations in pfcrt and pfmdr1 genes of Plasmodium falciparum isolates from Nigeria. Acta Trop (2011) 0.97
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children. Malar J (2011) 0.96
Do health workers' preferences influence their practices? Assessment of providers' attitude and personal use of new treatment recommendations for management of uncomplicated malaria, Tanzania. BMC Public Health (2012) 0.93
Randomized clinical trial of artemisinin versus non-artemisinin combination therapy for uncomplicated falciparum malaria in Madagascar. Malar J (2007) 0.92
Plasmodium falciparum gametocyte sex ratios in children with acute, symptomatic, uncomplicated infections treated with amodiaquine. Malar J (2008) 0.85
In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum. Antimicrob Agents Chemother (2004) 0.84
Efficacy of Artesunate + Sulphadoxine-Pyrimethamine (AS + SP) and Amodiaquine + Sulphadoxine-Pyrimethamine (AQ + SP) for Uncomplicated falciparum Malaria in Equatorial Guinea (Central Africa). J Trop Med (2009) 0.84
Should malaria treatment be guided by a point of care rapid test? A threshold approach to malaria management in rural Burkina Faso. PLoS One (2013) 0.82
Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes. Malar Res Treat (2013) 0.79
Gancidin W, a potential low-toxicity antimalarial agent isolated from an endophytic Streptomyces SUK10. Drug Des Devel Ther (2017) 0.75
In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for uncomplicated Plasmodium falciparum malaria in Malawi, 2014. Malar J (2016) 0.75
Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet (2013) 14.06
Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis (2006) 13.74
Overdiagnosis of malaria in patients with severe febrile illness in Tanzania: a prospective study. BMJ (2004) 11.96
First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children. N Engl J Med (2011) 10.79
Rapid diagnostic tests compared with malaria microscopy for guiding outpatient treatment of febrile illness in Tanzania: randomised trial. BMJ (2007) 10.03
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Lancet (2004) 9.24
Inequities among the very poor: health care for children in rural southern Tanzania. Lancet (2003) 8.79
Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. PLoS Med (2007) 6.80
A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants. N Engl J Med (2012) 6.64
Malaria: progress, perils, and prospects for eradication. J Clin Invest (2008) 6.54
Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48
Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in Tanzania. Lancet (2004) 5.91
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis (2009) 5.90
A research agenda to underpin malaria eradication. PLoS Med (2011) 5.34
Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination. Clin Microbiol Rev (2011) 5.15
Urbanization in sub-saharan Africa and implication for malaria control. Am J Trop Med Hyg (2004) 5.07
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial. Lancet (2007) 4.83
Hitting hotspots: spatial targeting of malaria for control and elimination. PLoS Med (2012) 4.68
Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA (2005) 4.57
Influence of rapid malaria diagnostic tests on treatment and health outcome in fever patients, Zanzibar: a crossover validation study. PLoS Med (2009) 4.55
Time to move from presumptive malaria treatment to laboratory-confirmed diagnosis and treatment in African children with fever. PLoS Med (2009) 4.49
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med (2008) 4.35
Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30
Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet (2003) 4.26
Child survival gains in Tanzania: analysis of data from demographic and health surveys. Lancet (2008) 4.03
New medicines to improve control and contribute to the eradication of malaria. Nat Rev Drug Discov (2009) 4.00
Factors affecting home delivery in rural Tanzania. Trop Med Int Health (2007) 3.91
Sustainable schistosomiasis control--the way forward. Lancet (2003) 3.86
Identification of hot spots of malaria transmission for targeted malaria control. J Infect Dis (2010) 3.86
Mass treatment with single-dose azithromycin for yaws. N Engl J Med (2015) 3.84
Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet (2005) 3.79
Serology: a robust indicator of malaria transmission intensity? Trends Parasitol (2007) 3.63
Challenges in routine implementation and quality control of rapid diagnostic tests for malaria--Rufiji District, Tanzania. Am J Trop Med Hyg (2008) 3.50
Some lessons for the future from the Global Malaria Eradication Programme (1955-1969). PLoS Med (2011) 3.42
The contribution of microscopy to targeting antimalarial treatment in a low transmission area of Tanzania. Malar J (2006) 3.31
Strengthening capacity for health research in Africa. Lancet (2008) 3.27
Soil-transmitted helminth infection in South America: a systematic review and geostatistical meta-analysis. Lancet Infect Dis (2013) 3.23
Evaluation of Olyset insecticide-treated nets distributed seven years previously in Tanzania. Malar J (2004) 3.21
Intermittent preventive treatment for malaria control administered at the time of routine vaccinations in Mozambican infants: a randomized, placebo-controlled trial. J Infect Dis (2006) 3.17
Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02
The use of antenatal and postnatal care: perspectives and experiences of women and health care providers in rural southern Tanzania. BMC Pregnancy Childbirth (2009) 2.95
Rapid assessment of malaria transmission using age-specific sero-conversion rates. PLoS One (2009) 2.94
Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One (2010) 2.90
Access to health care in contexts of livelihood insecurity: a framework for analysis and action. PLoS Med (2007) 2.89
Intracontinental spread of human invasive Salmonella Typhimurium pathovariants in sub-Saharan Africa. Nat Genet (2012) 2.86
Microbial larvicide application by a large-scale, community-based program reduces malaria infection prevalence in urban Dar es Salaam, Tanzania. PLoS One (2009) 2.85
Multiple parasite infections and their relationship to self-reported morbidity in a community of rural Côte d'Ivoire. Int J Epidemiol (2004) 2.84
Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J (2009) 2.83
Health and survival of young children in southern Tanzania. BMC Public Health (2008) 2.83
Integrated urban malaria control: a case study in dar es salaam, Tanzania. Am J Trop Med Hyg (2004) 2.80
The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis (2012) 2.70
A tool box for operational mosquito larval control: preliminary results and early lessons from the Urban Malaria Control Programme in Dar es Salaam, Tanzania. Malar J (2008) 2.70
Serologic markers for detecting malaria in areas of low endemicity, Somalia, 2008. Emerg Infect Dis (2010) 2.59
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania. Antimicrob Agents Chemother (2003) 2.57
Interdependence of domestic malaria prevention measures and mosquito-human interactions in urban Dar es Salaam, Tanzania. Malar J (2007) 2.57
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial. Lancet Infect Dis (2011) 2.54
Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis (2012) 2.53
The use of personal digital assistants for data entry at the point of collection in a large household survey in southern Tanzania. Emerg Themes Epidemiol (2007) 2.53
Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J (2010) 2.47
Mosquito nets and the poor: can social marketing redress inequities in access? Trop Med Int Health (2004) 2.44
Effect of irrigation and large dams on the burden of malaria on a global and regional scale. Am J Trop Med Hyg (2005) 2.43
Development and field evaluation of a synthetic mosquito lure that is more attractive than humans. PLoS One (2010) 2.42
Quality and comparison of antenatal care in public and private providers in the United Republic of Tanzania. Bull World Health Organ (2003) 2.42
Habitat characterization and spatial distribution of Anopheles sp. mosquito larvae in Dar es Salaam (Tanzania) during an extended dry period. Malar J (2005) 2.39
Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. Am J Trop Med Hyg (2006) 2.38
Long-term safety and efficacy of the RTS,S/AS02A malaria vaccine in Mozambican children. J Infect Dis (2009) 2.36